| Literature DB >> 29762147 |
Chrisandra Shufelt1, Joann Manson2.
Abstract
In the United States, nearly 10 million women are currently in the menopause transition and 2.25 million women are 51 years of age, which is the average age of menopause. Approximately 75% of these women will experience vasomotor symptoms such as hot flashes and night sweats. Menopause hormone therapy (HT) remains the most effective treatment for menopausal symptoms, but the decision to use HT is complex and requires balancing the benefits and risks for the individual patient. The decision also requires clinical judgment and shared decision making with the patient. In this review, we discuss the current guidelines for HT use, the benefits and risks for the individual patient and a novel algorithm and clinical decision support tool for menopausal symptom management that facilitates shared decision making between clinician and patient.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29762147 PMCID: PMC6059966 DOI: 10.1097/GRF.0000000000000378
Source DB: PubMed Journal: Clin Obstet Gynecol ISSN: 0009-9201 Impact factor: 2.190